These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris. Mokracka J; Gruszczyńska B; Kaznowski A APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307 [TBL] [Abstract][Full Text] [Related]
10. Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital. Pfeifer Y; Trifonova A; Pietsch M; Brunner M; Todorova I; Gergova I; Wilharm G; Werner G; Savov E Microb Drug Resist; 2017 Apr; 23(3):301-307. PubMed ID: 27459019 [TBL] [Abstract][Full Text] [Related]
11. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572 [TBL] [Abstract][Full Text] [Related]
13. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt. ElTaweel M; Said HS; Barwa R Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Genetic Environment of the bla Espinal P; Miró E; Ramoneda L; Flores M; Rivera A; Coll P; Navarro F Microb Drug Resist; 2017 Oct; 23(7):833-837. PubMed ID: 28304213 [TBL] [Abstract][Full Text] [Related]
15. Increased Resistance to Carbapenems in Bontron S; Poirel L; Kieffer N; Savov E; Trifonova A; Todorova I; Kueffer G; Nordmann P Microb Drug Resist; 2019 Jun; 25(5):663-667. PubMed ID: 30676261 [No Abstract] [Full Text] [Related]
16. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415 [TBL] [Abstract][Full Text] [Related]
17. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. Siebor E; Neuwirth C J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670 [TBL] [Abstract][Full Text] [Related]
18. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany. Lange F; Pfennigwerth N; Gerigk S; Gohlke F; Oberdorfer K; Purr I; Wohanka N; Roggenkamp A; Gatermann SG; Kaase M J Antimicrob Chemother; 2017 May; 72(5):1334-1339. PubMed ID: 28093482 [TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant Rubic Z; Soprek S; Jelic M; Novak A; Goic-Barisic I; Radic M; Tambic-Andrasevic A; Tonkic M Microb Drug Resist; 2021 Feb; 27(2):162-169. PubMed ID: 32429775 [TBL] [Abstract][Full Text] [Related]
20. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]